Coyle Financial Counsel’s Labcorp LH Stock Holding History

Coyle Financial Counsel’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-36	Closed	-$6K	–	181
2018 Q2	$6K	Buy	+36	New	+$5.43K	0.01%	155

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Coyle Financial Counsel's LH Position: Q3 2018 in Review

Coyle Financial Counsel sold out of Labcorp (LH) in Q3 2018, closing a stake of 36 shares — an estimated $6K sold.

Coyle Financial Counsel first reported a position in LH in Q2 2018 and held it in 1 quarter. The position peaked at $6K in Q2 2018. 793 funds tracked by Wall St. Rank hold LH as of Q3 2018.

Coyle Financial Counsel reported no remaining Labcorp position as of Q3 2018 after selling out during the quarter.
Coyle Financial Counsel sold 36 Labcorp shares in Q3 2018, an estimated $6K.
Coyle Financial Counsel first reported a position in Labcorp in Q2 2018 and held it in 1 quarter.
Coyle Financial Counsel's Labcorp position peaked at $6K in Q2 2018.
793 funds tracked by Wall St. Rank held Labcorp as of Q3 2018.

Based on Coyle Financial Counsel's 13F filing for Q3 2018, filed 13 Nov 2018.